OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor Cell-Derived Exosomal circ-PRKCI Promotes Proliferation of Renal Cell Carcinoma via Regulating miR-545-3p/CCND1 Axis
Yiguan Qian, Yang Li, Luwei Xu, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 123-123
Open Access | Times Cited: 15
Yiguan Qian, Yang Li, Luwei Xu, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 123-123
Open Access | Times Cited: 15
Showing 15 citing articles:
Exosomal circRNAs: Novel biomarkers and therapeutic targets for urinary tumors
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 22
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 22
Recent advances of exosomal circRNAs in cancer and their potential clinical applications
Qian Yi, Jiaji Yue, Yang Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Qian Yi, Jiaji Yue, Yang Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis
Fan Zhang, Dexian Wei, Shishun Xie, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109057-109057
Open Access | Times Cited: 9
Fan Zhang, Dexian Wei, Shishun Xie, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109057-109057
Open Access | Times Cited: 9
Role of the circRNA/miRNA/mRNA axis in Renal Cell Carcinoma: from gene regulation to metabolism and immunity
Zhengjun Xu, Yurong Dong, Kun Cui, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112183-112183
Open Access
Zhengjun Xu, Yurong Dong, Kun Cui, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112183-112183
Open Access
Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist
Yukang Lu, Mengting Zhang, Jiajun Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Yukang Lu, Mengting Zhang, Jiajun Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Roles of noncoding RNAs in septic acute kidney injury
Lili Yue, Yulu Gu, Juntian Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115269-115269
Open Access | Times Cited: 4
Lili Yue, Yulu Gu, Juntian Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115269-115269
Open Access | Times Cited: 4
Wogonin inhibits hepatoma cell proliferation by targeting miR‐27b‐5p/YWHAZ axis
Ming‐Yue Ma, Qian Wang, Shou‐Mei Wang, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 12
Closed Access | Times Cited: 4
Ming‐Yue Ma, Qian Wang, Shou‐Mei Wang, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 12
Closed Access | Times Cited: 4
hsa_circ_0003596, as a novel oncogene, regulates the malignant behavior of renal cell carcinoma by modulating glycolysis
QingZhi Xie, FuQiang Qin, Lihui Luo, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4
QingZhi Xie, FuQiang Qin, Lihui Luo, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Exosomal circRNAs: Deciphering the novel drug resistance roles in cancer therapy
Xi Li, Hanzhe Liu, Peiyu Xing, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 15, Iss. 2, pp. 101067-101067
Open Access | Times Cited: 1
Xi Li, Hanzhe Liu, Peiyu Xing, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 15, Iss. 2, pp. 101067-101067
Open Access | Times Cited: 1
Exosome in renal cell carcinoma progression and implications for targeted therapy
Xinwei Li, Wenjun Xiao, Hongmei Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Xinwei Li, Wenjun Xiao, Hongmei Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Identification of BRAF, CCND1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature
Zheyu Liu, Cheng Jin, Yi Zhang, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Zheyu Liu, Cheng Jin, Yi Zhang, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications
Rui Rui, Liqun Zhou, Shiming He
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Rui Rui, Liqun Zhou, Shiming He
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Role of Exosomal Non-Coding RNA in the Tumour Microenvironment of Genitourinary System Tumours
Shuang Wu, Chao Mu, Jiajia Sun, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 2
Shuang Wu, Chao Mu, Jiajia Sun, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 2
New perspectives of exosomes in urologic malignancies - mainly focus on biomarkers and tumor microenvironment
Hai Tang, Yizhi Liu, Jingwei Ke, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155645-155645
Closed Access
Hai Tang, Yizhi Liu, Jingwei Ke, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155645-155645
Closed Access
Tumor Supplying Artery Injection of Liposome@Sunitinib Could Effectively Inhibit the Progression of Kidney Tumor
Qingfeng Fu, G. Li, Lin Wang, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access
Qingfeng Fu, G. Li, Lin Wang, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access
